Gilead Sciences announces a major acquisition of German biotech firm Tubulis, with a deal valued at up to $5 billion, aimed at strengthening its oncology research and development pipeline.
A groundbreaking fossil discovery in China indicates that complex life forms evolved millions of years earlier than previously believed, challenging established evolutionary timelines.
Newly discovered fossils from China's Yunnan province indicate that complex life forms, including early ancestors of jellyfish and corals, evolved millions of years earlier than previously believed by scientists.
Avicanna Inc. announced its full year 2025 audited financial results, achieving positive adjusted EBITDA in Q4 2025 and near break-even performance for the full year with significant improvements across business units.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Swiss pharmaceutical giant Novartis has agreed to acquire US biotech firm Excellergy for up to $2 billion, expanding its portfolio in innovative therapies.
Avicanna Inc. announces its subsidiary SMGH has completed the first commercial export of organic certified CBG-dominant cannabis flower to Australia, expanding its global market reach.
Pharmaceutical giant Merck has announced a major strategic move, acquiring Terns Pharmaceuticals for $6.7 billion to enhance its oncology research and development efforts.
A new study on mice demonstrates that repeated cloning leads to significant genetic mutations, raising concerns about the long-term viability of cloning techniques.
The Canadian government announced $20 million in funding for genomics research projects across the country, including three at the University of Calgary, as part of a strategy to strengthen the economy amid global pressures.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Kane Biotech announces strategic expansion into U.S. government healthcare markets through partnership with Marathon Medical Corporation and new sales team development.
SeaStar Medical Holding Corporation announced CEO Eric Schlorff will participate in a fireside chat at the Life Sciences Investor Forum on March 11, 2026, discussing the company's innovative treatments for critically ill patients.
Mysterious Asgard archaea microbes, discovered in deep-sea environments, may hold critical insights into the evolutionary leap from simple to complex cellular life, reshaping our understanding of biology's early history.
A groundbreaking genetic analysis provides fresh insights into the complex mating patterns between early humans and Neanderthals, shedding light on our evolutionary history.
PyroGenesis Inc. has completed a primary testing campaign with a leading battery recycler, confirming plasma technology viability for recovering key minerals from lithium-ion batteries. The company is now positioned for potential equipment sales.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
A British Columbia man has been cured of a rare disease through groundbreaking gene-editing technology, marking a global medical milestone with profound implications for future treatments.
A Western University team led by Professor Bodumil Karas is studying diatom genetics, opening doors to innovative uses in nutrition and renewable energy.
GSK PLC has agreed to purchase Canadian biotech firm 35Pharma Inc. for US$950 million, acquiring an early-stage pulmonary hypertension drug called HS235. The deal comes as CEO Luke Miels works to expand GSK's portfolio ahead of key patent expirations.
Scientists have extracted DNA from mummified cheetah remains found in a hyper-arid cave, uncovering unexpected genetic details that reshape our understanding of the species' history and adaptation.
Kane Biotech announces the publication of a peer-reviewed article on its revyve Antimicrobial Wound Gel in the International Wound Journal, highlighting its efficacy and safety.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
BioNTech has initiated a legal action against Moderna, alleging patent infringement related to their COVID-19 vaccine technologies, marking a significant dispute in the pharmaceutical industry.
Kane Biotech Inc. has signed non-exclusive distribution agreements with Patient Care Medical and Life Biologics to expand commercial activities for its revyve Antimicrobial Wound Gel products in the United States.
Canadian biotech firm Stoked Bio has obtained exclusive global rights from McMaster University to develop Enterololin, a novel narrow-spectrum antibiotic with potential applications for Crohn's disease treatment.
A McGill University study finds that higher urine concentrations in microbial fuel cells significantly improve electricity generation, offering sustainable solutions for wastewater treatment and off-grid power.
Researchers at McGill University in Montreal have announced a breakthrough in converting human urine into usable energy, potentially offering a sustainable waste-to-power solution.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Biotechnology firm Moderna exceeded quarterly revenue expectations, driven by resilient sales of its COVID-19 vaccines, highlighting ongoing market demand.
Kane Biotech announces the resumption of commercial activities for its revyve Antimicrobial Wound Gel line in the U.S. and Canada, alongside key executive appointments to drive North American business development.
Moderna's stock price declined following the FDA's decision not to review its new flu vaccine application, impacting investor confidence in the biotech firm's pipeline.
BioAro Inc. secures UAE regulatory approval for its AI-enabled BioActive Longevity Stack, marking a strategic expansion into the Middle East market with personalized health solutions.
A Miami resident has cloned his beloved Boston Terrier, Lucas, after the dog died from lymphoma, using advanced biotechnology to preserve their bond.
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Pharmaceutical giant Eli Lilly announces a major acquisition of therapy developer Orna Therapeutics, with the deal potentially reaching $2.4 billion in value.
